Concepedia

Maureen Highkin

MH

21

Publications

1.4K

Citations

17

H-Index

1984

Active since

Affiliations

Monsanto (United States)(Current)

Pfizer (United States)

University of Pennsylvania

Washington University in St. Louis

Maureen Highkin is an author at Monsanto (United States) specializing in medicine, pharmacology, and virology.

ORCID

Top concepts

Publications per year

1984–2023

21

Publications

21

Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1

Mark E. Schnute, Matthew D. McReynolds, Tom Kasten et al. · Biochemical Journal · 2012 · 274 citations

, , +20

Characterization of the Cytoprotective Action of Peroxynitrite Decomposition Catalysts

Thomas P. Misko, Maureen Highkin, Amy W. Veenhuizen et al. · Journal of Biological Chemistry · 1998 · 230 citations · Full text

Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression

Jessica Silva-Fisher, Ha X. Dang, Nicole M. White et al. · Nature Communications · 2020 · 127 citations · Full text

Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization

Ehud Lavi, Donald H. Gilden, Maureen Highkin et al. · Journal of Virology · 1984 · 100 citations · Full text

, , +15

Limbic encephalitis after inhalation of a murine coronavirus.

Ehud Lavi, Paul S. Fishman, Maureen Highkin et al. · PubMed · 1988 · 91 citations

Rows per page

1–5 of 21